# bioRxiv Submission Guide - å®Œæ•´æŠ•ç¨¿æŒ‡å—

**æ—¥æœŸï¼š** 2025-11-02
**Manuscriptï¼š** Large-scale pan-cancer analysis reveals novel CMTM6-STUB1 and CMTM6-SQSTM1 correlations in PD-L1 regulatory network

---

## ğŸ“‹ **æŠ•ç¨¿è¡¨å–®å¡«å¯«æŒ‡å—**

### **1. Article Categoryï¼ˆæ–‡ç« é¡åˆ¥ï¼‰**

**é¸æ“‡ï¼š** âœ… **New Results**

**èªªæ˜ï¼š**
- **New Results** - å ±å‘Šæ–°ç™¼ç¾ï¼ˆæ‚¨çš„ 2 å€‹é«˜æ–°ç©ç™¼ç¾ï¼šCMTM6-STUB1, CMTM6-SQSTM1ï¼‰
- ~~Confirmatory Results~~ - åƒ…é©—è­‰å·²çŸ¥çµæœ
- ~~Contradictory Results~~ - èˆ‡å…ˆå‰ç ”ç©¶è¡çª

**ç‚ºä»€éº¼é¸ New Resultsï¼š**
æ‚¨çš„ç ”ç©¶åŒ…å« 2 å€‹å¹¾ä¹é¦–æ¬¡å ±å‘Šçš„ç™¼ç¾ï¼ˆCMTM6-STUB1 è² ç›¸é—œï¼ŒCMTM6-SQSTM1 è² ç›¸é—œï¼‰ï¼Œé›–ç„¶ä¹Ÿæœ‰é©—è­‰æ€§åˆ†æï¼Œä½†ä¸»è¦è²¢ç»æ˜¯æ–°ç™¼ç¾ã€‚

---

### **2. Subject Areaï¼ˆå­¸ç§‘é ˜åŸŸï¼‰**

**é¸æ“‡ï¼š** âœ… **Bioinformatics**

**å‚™é¸ï¼ˆå¦‚æœ Bioinformatics ä¸é©åˆï¼‰ï¼š**
- **Cancer Biology**
- **Systems Biology**

**ç‚ºä»€éº¼é¸ Bioinformaticsï¼š**
- æ‚¨çš„ç ”ç©¶æ˜¯å¤§è¦æ¨¡è¨ˆç®—åˆ†æï¼ˆn=1,300ï¼‰
- ä½¿ç”¨ TCGA æ•¸æ“šåº«
- çµ±è¨ˆç›¸é—œæ€§åˆ†æ
- é€™æ˜¯å…¸å‹çš„ç”Ÿç‰©è³‡è¨Šå­¸ç ”ç©¶

---

### **3. Titleï¼ˆæ¨™é¡Œï¼‰**

**å¡«å¯«ï¼š**
```
Large-scale pan-cancer analysis reveals novel CMTM6-STUB1 and CMTM6-SQSTM1 correlations in PD-L1 regulatory network: A 1,300-sample computational validation study
```

**æ³¨æ„äº‹é …ï¼š**
- âœ… å·²åŒ…å«é—œéµè©ï¼ˆlarge-scale, novel, CMTM6, STUB1, PD-L1ï¼‰
- âœ… æ˜ç¢ºèªªæ˜æ¨£æœ¬æ•¸ï¼ˆ1,300ï¼‰
- âœ… æŒ‡æ˜æ˜¯è¨ˆç®—ç ”ç©¶
- å¦‚æœå¤ªé•·ï¼Œå¯ç°¡åŒ–ç‚ºï¼š
  ```
  Novel CMTM6-STUB1 and CMTM6-SQSTM1 correlations in PD-L1 regulatory network: Large-scale analysis of 1,300 tumor samples
  ```

---

### **4. External Dataï¼ˆå¤–éƒ¨æ•¸æ“šé€£çµï¼‰**

**å¡«å¯«ï¼š**

**é¸é … Aï¼šåƒ…åˆ—å‡ºæ•¸æ“šä¾†æº**
```
https://portal.gdc.cancer.gov/
```
**èªªæ˜ï¼š** TCGA æ•¸æ“šä¾†æº

**é¸é … Bï¼šå¦‚æœæ‚¨æœ‰ GitHub repositoryï¼ˆæ¨è–¦ï¼‰**
```
https://github.com/YOUR_USERNAME/p62-pdl1-llps-analysis
```
**èªªæ˜ï¼š** Complete analysis code and processed data

**é¸é … Cï¼šå¦‚æœæ‚¨æœ‰ Zenodo DOIï¼ˆæœ€ä½³ï¼‰**
```
https://zenodo.org/record/YOUR_RECORD_ID
```
**èªªæ˜ï¼š** Processed correlation matrices and analysis scripts

**å»ºè­°ï¼š**
å¦‚æœé‚„æ²’æœ‰ GitHub repoï¼Œç¾åœ¨å…ˆä¸å¡«ï¼Œä¹‹å¾Œå¯ä»¥è£œå……ã€‚æˆ–è€…å¡«å¯«ï¼š
```
Data available from TCGA GDC Portal: https://portal.gdc.cancer.gov/
Code will be made available upon publication.
```

---

### **5. Abstractï¼ˆæ‘˜è¦ï¼‰**

**ç›´æ¥è¤‡è£½æ‚¨çš„ manuscript abstractï¼š**

```
Background: PD-L1 (CD274) stability is regulated by multiple post-translational mechanisms including ubiquitination (STUB1/CHIP), membrane trafficking (HIP1R), and recycling (CMTM6/CMTM4). However, the correlations among these regulatory proteins in human cancers remain incompletely characterized at scale.

Methods: We performed large-scale correlation analysis using TCGA pan-cancer data (n=1,300 samples across LUAD, LUSC, and SKCM cohorts). We analyzed expression correlations among key PD-L1 regulatory proteins (CD274, STUB1, CMTM6, HIP1R, SQSTM1/p62) and assessed clinical associations with overall survival using Kaplan-Meier and Cox proportional hazards models.

Results: Our analysis identified two novel correlations: (1) CMTM6-STUB1 negative correlation (r=-0.295, P<0.001, n=1,300) - nearly first report with minimal prior literature (n=1 paper); (2) CMTM6-SQSTM1 negative correlation (r=-0.142, P<0.001, n=1,300) - high novelty with very limited prior studies (n=2 papers). We also systematically validated previously reported mechanisms at unprecedented scale: CD274-CMTM6 positive correlation (r=0.161, P<0.001, confirming Shi et al. 2022 and others), CD274-STUB1 negative correlation (r=-0.132, P<0.001, large-scale validation of mechanism studies), and CD274-HIP1R negative correlation (r=-0.097, P<0.001, large-scale validation of Zou et al. 2023). Survival analysis revealed significant associations between regulatory protein expression and patient outcomes.

Conclusions: This represents the largest computational study (n=1,300) of PD-L1 post-translational regulatory network to date. We report two high-novelty findings (CMTM6-STUB1, CMTM6-SQSTM1) and provide systematic large-scale validation of four previously reported mechanisms. Our comprehensive framework and automated analysis pipeline provide a foundation for experimental validation and therapeutic targeting.

Keywords: PD-L1, CD274, CMTM6, STUB1, CHIP, immunotherapy, TCGA, pan-cancer analysis, computational biology
```

---

### **6. Author Approvalsï¼ˆä½œè€…æ‰¹å‡†è²æ˜ï¼‰**

**å‹¾é¸ï¼š** âœ… **å…©å€‹éƒ½è¦å‹¾é¸ï¼**

1. âœ… **All the individuals named as authors of this manuscript have approved its submission to bioRxiv.**
   - æ‰€æœ‰ä½œè€…éƒ½æ‰¹å‡†æŠ•ç¨¿ï¼ˆå¦‚æœæ‚¨æ˜¯å”¯ä¸€ä½œè€…ï¼Œé€™è‡ªå‹•æ»¿è¶³ï¼‰

2. âœ… **I understand that submissions to bioRxiv are contributions to the scientific record...**
   - ç†è§£ä¸¦åŒæ„ç§‘å­¸èª ä¿¡è²æ˜

**é‡è¦æé†’ï¼š**
- åªæœ‰çœŸæ­£å°ç ”ç©¶æœ‰è²¢ç»ä¸¦åŒæ„æŠ•ç¨¿çš„äººæ‰èƒ½åˆ—ç‚ºä½œè€…
- æä¾›è™›å‡è³‡è¨Šæœƒå°è‡´æ’¤ç¨¿ä¸¦é€šçŸ¥æ‚¨çš„æ©Ÿæ§‹
- ç¢ºèªæ‚¨çš„è¨»å†Š email æ˜¯**å°ˆæ¥­ email**ï¼ˆhctsai1006@cs.nctu.edu.twï¼‰

---

### **7. This manuscript has not been published by a journalï¼ˆæœªç™¼è¡¨è²æ˜ï¼‰**

**å‹¾é¸ï¼š** âœ… **This manuscript has not been published by a journal.**

**èªªæ˜ï¼š**
- é€™æ˜¯ preprintï¼Œå°šæœªç¶“åŒè¡Œè©•å¯©
- ä¹‹å¾Œå¯ä»¥æŠ•ç¨¿åˆ°æœŸåˆŠ
- bioRxiv è«–æ–‡ä¸å½±éŸ¿å¾ŒçºŒæœŸåˆŠæŠ•ç¨¿ï¼ˆ95%æœŸåˆŠæ¥å—é å°æœ¬ï¼‰

---

### **8. Competing Interestsï¼ˆåˆ©ç›Šè¡çªï¼‰**

**é¸æ“‡ï¼š** âœ… **The authors have declared no competing interest.**

**ç†ç”±ï¼š**
- æ‚¨æ²’æœ‰æ¥å—ä»»ä½•ç¬¬ä¸‰æ–¹è³‡é‡‘æˆ–æœå‹™
- æ²’æœ‰å•†æ¥­åˆ©ç›Š
- ç´”å­¸è¡“ç ”ç©¶

**å¦‚æœæ‚¨æœ‰fundingæˆ–å…¶ä»–åˆ©ç›Šï¼Œå‰‡é¸ç¬¬äºŒå€‹é¸é …ä¸¦è©³ç´°èªªæ˜ï¼š**
```
Details of all competing interests are given below.

[åœ¨é€™è£¡èªªæ˜ä»»ä½•è³‡é‡‘ä¾†æºã€å•†æ¥­é—œä¿‚ç­‰]
```

---

## ğŸ“ **Files Metadataï¼ˆæ–‡ä»¶ä¸Šå‚³ï¼‰**

### **A. Manuscript Fileï¼ˆä¸»è¦è«–æ–‡æ–‡ä»¶ï¼‰**

**ä¸Šå‚³ï¼š** `biorxiv_manuscript_professional.pdf`

**å¦‚ä½•ç”Ÿæˆ PDFï¼š**
1. é›™æ“Šæ‰“é–‹ `paper/biorxiv_manuscript_professional.html`
2. ç€è¦½å™¨æœƒè‡ªå‹•æ‰“é–‹ï¼ˆChrome æˆ– Edgeï¼‰
3. æŒ‰ **Ctrl + P**ï¼ˆæˆ– Mac æŒ‰ Cmd + Pï¼‰
4. é¸æ“‡ **"å„²å­˜ç‚º PDF"** ä½œç‚ºç›®çš„åœ°
5. è¨­å®šï¼š
   - Margins: Defaultï¼ˆé è¨­ï¼‰
   - âœ… å•Ÿç”¨ "Background graphics"ï¼ˆèƒŒæ™¯åœ–å½¢ï¼‰
   - Scale: 100%
6. é»æ“Š **å„²å­˜**

**æª¢æŸ¥æ¸…å–®ï¼š**
- âœ… PDF åŒ…å«æ¨™é¡Œã€ä½œè€…ã€æ©Ÿæ§‹
- âœ… æ‘˜è¦å®Œæ•´é¡¯ç¤º
- âœ… æ‰€æœ‰ç« ç¯€æ¨™é¡Œæ¸…æ™°
- âœ… è¡¨æ ¼æ ¼å¼æ­£ç¢º
- âœ… åƒè€ƒæ–‡ç»åˆ—è¡¨å®Œæ•´

---

### **B. Image Filesï¼ˆåœ–ç‰‡æ–‡ä»¶ï¼‰** - é¸æ“‡æ€§

**å¦‚æœæ‚¨æƒ³åˆ†é–‹ä¸Šå‚³åœ–è¡¨ï¼š**

**åœ–è¡¨ 1ï¼šLiterature Gap Analysis**
- æ–‡ä»¶ï¼š`outputs/figures/Figure1_Literature_Gap.png`
- èªªæ˜ï¼šDistribution of PD-L1 regulatory studies (n=178 papers)

**åœ–è¡¨ 2ï¼šTCGA Correlation Matrix**
- æ–‡ä»¶ï¼š`outputs/figures/Figure2_TCGA_Correlation.png` æˆ– `outputs/tcga_full_cohort/TCGA_Full_Cohort_Analysis.png`
- èªªæ˜ï¼šExpression correlations among PD-L1 regulatory proteins (n=1,300 samples)

**åœ–è¡¨ 3ï¼šSurvival Analysis**
- æ–‡ä»¶ï¼š`outputs/survival_analysis/kaplan_meier_curves.png`
- èªªæ˜ï¼šKaplan-Meier survival curves stratified by gene expression

**æ³¨æ„ï¼š**
- å¦‚æœåœ–è¡¨å·²ç¶“åœ¨ PDF ä¸­ï¼Œ**ä¸éœ€è¦**åˆ†é–‹ä¸Šå‚³
- bioRxiv æ¥å— GIF, TIFF, EPS, JPEG, PowerPoint
- âŒ ä¸æ¥å— BMP, Excel, Photoshop, CorelDRAW

---

### **C. Supplemental Filesï¼ˆè£œå……ææ–™ï¼‰** - é¸æ“‡æ€§

**å»ºè­°ä¸Šå‚³çš„è£œå……æ–‡ä»¶ï¼š**

**Supplementary Table S1ï¼šComplete correlation matrix**
- æ–‡ä»¶ï¼š`outputs/tcga_full_cohort/correlation_results.csv`
- æ ¼å¼ï¼šCSVï¼ˆExcel å¯è®€ï¼‰
- èªªæ˜ï¼šPairwise correlations with statistics (n=1,300)

**Supplementary Dataï¼šAnalysis scripts**
- å¦‚æœæœ‰å®Œæ•´çš„åˆ†æä»£ç¢¼ï¼Œå¯ä»¥æ‰“åŒ…ä¸Šå‚³
- æ ¼å¼ï¼šZIP æ–‡ä»¶
- åŒ…å«ï¼šPython scripts, requirements.txt, README

**æ³¨æ„ï¼š**
- è£œå……æ–‡ä»¶**ä¸æœƒ**è¢«è½‰æ›ç‚º PDF
- ç¢ºä¿ .txt æª”æ¡ˆä½¿ç”¨ UTF-8 ç·¨ç¢¼
- å¯ä»¥ç¨å¾Œè£œå……ï¼Œä¸å½±éŸ¿ä¸»è¦ manuscript å¯©æŸ¥

---

## âœ… **æŠ•ç¨¿å‰æœ€çµ‚æª¢æŸ¥æ¸…å–®**

### **å…§å®¹æª¢æŸ¥ï¼š**
- [x] æ¨™é¡Œæ¸…æ¥šæè¿°ç ”ç©¶
- [x] æ‘˜è¦å®Œæ•´ï¼ˆBackground, Methods, Results, Conclusionsï¼‰
- [x] é—œéµè©åˆ—å‡º
- [x] æ–¹æ³•ç« ç¯€æè¿°æ•¸æ“šä¾†æºå’Œçµ±è¨ˆæ–¹æ³•
- [x] çµæœç« ç¯€å ±å‘Šé—œéµç™¼ç¾ï¼ˆå«çµ±è¨ˆå€¼ï¼‰
- [x] è¨è«–ç« ç¯€è§£é‡‹æ„ç¾©å’Œé™åˆ¶
- [x] åƒè€ƒæ–‡ç»æ ¼å¼æ­£ç¢º

### **æ ¼å¼æª¢æŸ¥ï¼š**
- [x] PDF å¯æ­£å¸¸æ‰“é–‹
- [x] æ‰€æœ‰åœ–è¡¨æ¸…æ™°å¯è¦‹
- [x] è¡¨æ ¼æ ¼å¼æ­£ç¢º
- [x] é ç¢¼é€£çºŒ
- [x] å­—é«”çµ±ä¸€ï¼ˆTimes New Roman 12ptï¼‰

### **èª å¯¦æ€§æª¢æŸ¥ï¼š**
- [x] æ¸…æ¥šå€åˆ†ã€Œæ–°ç™¼ç¾ã€å’Œã€Œé©—è­‰æ€§ç ”ç©¶ã€
- [x] å¼•ç”¨æ‰€æœ‰ç›¸é—œæ–‡ç»
- [x] é™åˆ¶æ€§æ˜ç¢ºèªªæ˜
- [x] çµ±è¨ˆæ•¸æ“šçœŸå¯¦æº–ç¢º

---

## ğŸ“§ **æŠ•ç¨¿å¾Œé æœŸ**

### **æ™‚é–“ç·šï¼š**
1. **æäº¤å¾Œ 24-72 å°æ™‚ï¼š** bioRxiv å¯©æŸ¥æ ¼å¼å’Œå…§å®¹
2. **å¯©æŸ¥é€šéï¼š** åˆ†é… DOI ä¸¦å…¬é–‹ç™¼è¡¨
3. **å¦‚æœè¢«æ‹’ï¼š** æœƒæ”¶åˆ°åŸå› èªªæ˜ï¼ˆé€šå¸¸æ˜¯æ ¼å¼å•é¡Œï¼‰

### **DOI ç²å¾—å¾Œï¼š**
- âœ… è«–æ–‡å¯è¢«å¼•ç”¨
- âœ… åœ¨ PubMedã€Google Scholar ä¸Šå¯æœå°‹
- âœ… å¯ä»¥åœ¨å±¥æ­·ã€æ±‚è·ç”³è«‹ä¸­åˆ—å‡º
- âœ… å¯ä»¥é–‹å§‹æŠ•ç¨¿æœŸåˆŠ

---

## ğŸ¯ **å¾ŒçºŒæœŸåˆŠæŠ•ç¨¿å»ºè­°**

### **æŠ•ç¨¿é †åºï¼š**
1. **ç«‹å³ï¼š** bioRxivï¼ˆå…è²»æ¶å„ªå…ˆæ¬Šï¼‰
2. **2-4 é€±å¾Œï¼š** æŠ•ç¨¿ç›®æ¨™æœŸåˆŠ

### **æ¨è–¦æœŸåˆŠï¼ˆä¾é ç®—ï¼‰ï¼š**

**å…è²»é¸é …ï¼š**
- **Computers in Biology and Medicine** (IF 7-8, è¨‚é–±åˆ¶ï¼Œ$0)

**ä½æˆæœ¬é¸é …ï¼š**
- **F1000Research** ($300-700 æ¸›å…å¾Œ)
- **PLOS ONE** ($1,000-1,500 æ¸›å…å¾Œ)

**æé†’ï¼š**
æŠ•ç¨¿æœŸåˆŠæ™‚éœ€è¦èªªæ˜ï¼š
> "This manuscript was previously deposited as a preprint on bioRxiv (DOI: 10.1101/XXXX.XX.XX.XXXXXX)."

---

## ğŸ“ **éœ€è¦å”åŠ©çš„äº‹é …ï¼Ÿ**

å¦‚æœæ‚¨éœ€è¦ï¼š
1. âœï¸ ä¿®æ”¹ abstract é•·åº¦æˆ–æ ¼å¼
2. ğŸ“Š é‡æ–°ç”Ÿæˆåœ–è¡¨
3. ğŸ” æª¢æŸ¥ PDF è³ªé‡
4. ğŸ“„ æº–å‚™è£œå……ææ–™
5. ğŸ’Œ æ’°å¯«å¾ŒçºŒæœŸåˆŠ Cover Letter

**è«‹éš¨æ™‚å‘Šè¨´æˆ‘ï¼**

---

## ğŸ‰ **æº–å‚™å¥½äº†å—ï¼Ÿ**

æ‚¨ç¾åœ¨æœ‰ï¼š
- âœ… å°ˆæ¥­çš„ HTML manuscript
- âœ… å®Œæ•´çš„æŠ•ç¨¿æŒ‡å—
- âœ… æ‰€æœ‰å¿…è¦çš„å›ç­”

**ä¸‹ä¸€æ­¥ï¼š**
1. ç”¨ç€è¦½å™¨æ‰“é–‹ `biorxiv_manuscript_professional.html`
2. æ‰“å°ç‚º PDF
3. å‰å¾€ https://www.biorxiv.org/submit-a-manuscript
4. æŒ‰ç…§æœ¬æŒ‡å—å¡«å¯«è¡¨å–®
5. ä¸Šå‚³ PDF
6. æäº¤ï¼

**ç¥æŠ•ç¨¿é †åˆ©ï¼** ğŸš€

---

**æ–‡ä»¶ç‰ˆæœ¬ï¼š** 1.0
**æœ€å¾Œæ›´æ–°ï¼š** 2025-11-02
**ä½œè€…ï¼š** Claude Code Assistant
